Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong · Delayed Price · Currency is HKD 7.03
+0.10 (1.44%)
Jun 1, 2026, 4:08 PM HKT
HKG:3613 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 397.22 | 500.28 | 540.39 | 645.88 | 607.84 |
Depreciation & Amortization | 92.55 | 85.98 | 80.45 | 73.6 | 69.02 |
Other Amortization | 5.81 | 2.14 | 2.06 | 1.87 | 0.96 |
Loss (Gain) From Sale of Assets | -0.85 | -2.41 | 0.38 | -0.03 | 0.44 |
Asset Writedown & Restructuring Costs | - | - | - | 0.05 | - |
Loss (Gain) From Sale of Investments | 4.89 | - | -2.88 | - | - |
Loss (Gain) on Equity Investments | 8.73 | -2.06 | 3.26 | 1.54 | -0.26 |
Provision & Write-off of Bad Debts | 61.59 | 1.95 | 21.19 | 6.48 | 7.52 |
Other Operating Activities | -9.95 | -28.78 | -149.7 | 144.97 | 31.62 |
Change in Accounts Receivable | 58.98 | -116.75 | 492.15 | -434.16 | 23.19 |
Change in Inventory | 249.72 | -584.26 | -543.6 | -47 | 64.96 |
Change in Accounts Payable | -39.15 | -73.35 | 17.12 | 154.24 | -28.1 |
Operating Cash Flow | 829.52 | -217.25 | 460.83 | 547.44 | 777.17 |
Operating Cash Flow Growth | - | - | -15.82% | -29.56% | 569.66% |
Capital Expenditures | -41.18 | -43.17 | -21.87 | -38.51 | -23.43 |
Sale of Property, Plant & Equipment | 0.08 | 0 | 0.06 | 0.13 | 0.02 |
Cash Acquisitions | - | - | - | -3.26 | -13.55 |
Investment in Securities | -4.7 | 1,332 | -1,126 | 362.27 | -234 |
Other Investing Activities | 44.37 | 65.81 | 69.17 | 14.79 | 5.22 |
Investing Cash Flow | -1.43 | 1,355 | -1,079 | 335.41 | -265.73 |
Long-Term Debt Issued | - | - | - | - | 0.39 |
Long-Term Debt Repaid | -68.15 | -63.97 | -58.73 | -56.48 | -50.66 |
Net Debt Issued (Repaid) | -68.15 | -63.97 | -58.73 | -56.48 | -50.28 |
Common Dividends Paid | -292.99 | -276.24 | -276.24 | -234.39 | -200.9 |
Other Financing Activities | -17.51 | -15.09 | -37.21 | -35.28 | -27.47 |
Financing Cash Flow | -378.64 | -355.3 | -372.18 | -535.42 | -278.65 |
Foreign Exchange Rate Adjustments | 5.32 | -9.04 | -1.28 | -16.78 | 1.48 |
Net Cash Flow | 454.77 | 773.26 | -991.15 | 330.66 | 234.26 |
Free Cash Flow | 788.34 | -260.42 | 438.97 | 508.94 | 753.74 |
Free Cash Flow Growth | - | - | -13.75% | -32.48% | 630.55% |
Free Cash Flow Margin | 52.09% | -16.16% | 28.79% | 29.40% | 48.44% |
Free Cash Flow Per Share | 0.94 | -0.31 | 0.52 | 0.61 | 0.90 |
Cash Interest Paid | 5.66 | 6.48 | 5.98 | 4.66 | 4.71 |
Cash Income Tax Paid | 77.13 | 108.42 | 231.04 | 19.16 | 137.84 |
Levered Free Cash Flow | 686.19 | -382.46 | 318.64 | 315.94 | 593.34 |
Unlevered Free Cash Flow | 689.73 | -378.41 | 322.38 | 318.85 | 596.28 |
Change in Working Capital | 269.55 | -774.35 | -34.32 | -326.91 | 60.04 |